Kumate J

Language: Spanish
References: 16
Page: 239-241
PDF size: 68.06 Kb.

Text Extraction

No Abstract

REFERENCES

1. Brodie M, Park WH. Active immunization against poliomyelitis. Am J Pub Health. 1936; 26: 119-25.

2. Enders J, Weller T, Robbins F. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science. 1949; 109: 85-7.

3. Francis T, Korns R, Voight R, et. al. An evaluation of the 1954 poliomyelitis vaccine trials. Ann Arbor: University of Michigan; 1955.

4. Wilson G. The Cutter incident. En: “The hazards of immunization”. London: The Athlone Press; 1967. p. 44-8.

5. Katz SL. From culture to vaccine -Salk and Sabin. N Engl J Med. 2004; 315: 1485-7.

6. Kolmer JA. Vaccination against acute anterior poliomyelitis. Am J Pub Health. 1936; 26: 126-35.

7. Lepow ML. Advances in virology -Weller and Robbins. N Engl J Med. 2004; 315: 1485-7.

8. Markel H. April 12, 1955 -Tommy Francis and the Salk vaccine. N Engl J Med. 2005; 352: 1408-10.

9. Offit PA. The Cutter incident, 50 years later. N Engl J Med. 2005; 352: 1411-2.

10. Paul JE. Indications for vaccination against poliomyelitis. JAMA. 1956; 162: 1585-96.

11. Paul JR. Endemic and epidemic trends of poliomyelitis in Central and South America. Bull World Health Organ 1958; 19: 747-58.

12. Paul JR, Riordan JT, Melnick JL. Antibodies to three different antigenic types of poliomyelitis in sera from north alaskan eskimos. Am J Hyg. 1951; 54: 275-85.

13. Plotkin SA, Vidas E. Poliovirus vaccine inactivated. En: “Vaccines”. 4th. ed. Philadelphia: Plotkin & Orenstein, Saunders; 2004. p. 625-49.

14. Robbins FC. The history of polio vaccine development. En: “Vaccines”. 4th. ed. Philadelphia: Plotkin & Orenstein, Saunders; 2004. p. 17-30.

15. Rosen FS. Isolation of poliovirus -John Enders and the Nobel Prize. N Engl J Med. 2004; 351: 1481-3

16. Setre B, Shaffer M. !A world without polio”. St. André les-verges. Aventis Pasteur. 2003.